Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TN › Lewisburg › NPI 1578591756
Hospital

Maury Regional Hospital Marshall Medical Center

Maury Regional Hospital Marshall Medical Center was paid $5.52M by Medicaid between Jan 2018 and Dec 2024, across 51 billing codes. Its largest line is 99283, emergency room visit (moderate) — 51% of everything it billed.

33Billing provider infoMAURY REGIONAL HOSPITAL MARSHALL MEDICAL CENTER
LEWISBURG, TN 37091
33aNPI1578591756assigned 06/28/2006
28Total paid$5.52M
24GClaims59,650
24DCodes billed51
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Medicare Defined Swing Bed Hospital Unit providers in Tennessee

Rank by total paid#1 of 5
Median peer was paid$1.63M
This provider vs. median3.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20188,968$731K
20199,047$753K
20206,244$447K
20218,644$784K
202210,282$1.07M
20239,513$969K
2024incomplete6,952$762K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 51% 13,891 12,828 $2.81M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 23% 4,275 3,919 $1.28M
99282 Emergency department visit for the evaluation and management, low to moderate severity 6.5% 3,201 2,990 $361K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 6.2% 2,995 2,830 $344K
97530 Therapeutic activities, direct patient contact, each 15 minutes 2.8% 2,931 691 $152K
80053 Comprehensive metabolic panel 1.7% 7,526 6,716 $95K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 1.4% 324 287 $77K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.0% 935 889 $55K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 6,873 6,191 $55K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,090 1,046 $32K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 412 135 $27K
71046 Radiologic examination, chest; 2 views <1% 952 889 $26K
39 more codes
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 740 $26K
81001 <1% 4,638 $24K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 135 $22K
G0378 Hospital observation service, per hour <1% 78 $19K
96375 Therapeutic injection; each additional sequential IV push <1% 706 $18K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 781 $18K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 870 $14K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 182 $12K
87086 Culture, bacterial; quantitative colony count, urine <1% 810 $10K
96361 Intravenous infusion, hydration; each additional hour <1% 435 $8K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 459 $6K
84484 <1% 285 $5K
71045 Radiologic examination, chest; single view <1% 249 $4K
81025 <1% 377 $3K
36415 Collection of venous blood by venipuncture <1% 1,207 $2K
84703 <1% 212 $2K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 82 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 261 $2K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 59 $2K
83690 <1% 136 $2K
87807 <1% 107 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 51 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 450 $1K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 27 $883.06
87081 <1% 64 $798.43
87430 <1% 25 $392.01
85610 <1% 44 $190.98
J2270 Injection, morphine sulfate, up to 10 mg <1% 30 $106.89
85379 <1% 26 $95.97
83735 <1% 16 $94.03
82550 <1% 12 $84.74
81003 <1% 12 $67.84
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 55 $64.12
87040 <1% 14 $51.90
83605 <1% 15 $26.56
94726 0% 13 $0.00
A9270 Non-covered item or service 0% 534 $0.00
83036 Hemoglobin; glycosylated (A1C) 0% 24 $0.00
82962 0% 24 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWHITLOCK, GREGORY (VP FINANCE/IT)
Same official

Other billing entities under WHITLOCK, GREGORY

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.